Rylaze

Product NDC
68727-900
11-digit product format
687270900
Labeler code
68727
Product ID
68727-900_cca29ff5-d000-43da-b64a-c65816a8a9c4
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
asparaginase erwinia chrysanthemi (recombinant)-rywn
Dosage form
INJECTION
Route
INTRAMUSCULAR
Labeler
Jazz Pharmaceuticals, Inc.
Application
BLA761179
Marketing category
BLA
Marketing start
2021-06-30
Substance
ASPARAGINASE
Active strength
20 mg/mL
Pharmacologic classes
Asparaginase [CS], Asparagine-specific Enzyme [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Rylaze
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ASPARAGINASE20 mg/mL

Harmonized Identifiers#

Field, Values table
FieldValues
UniiG4FQ3CKY5R
Rxcui2561251, 2561256

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
ecb42c05-a297-4ddf-bbd1-f324912e7232Product name120220125
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68727-900-01Rylaze0.5 mL in 1 VIAL, SINGLE-DOSEINJECTION0.57
68727-900-03Rylaze3 in 1 CARTONINJECTION37

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
68727-900-01ML - Milliliter68727-900bae545c0-eb51-4e5b-80b3-7f4684dc1c2712021-08-05
68727-900-03ML - Milliliter68727-900f9e8a75a-28d1-4d27-9105-b693d1911f0512021-08-05

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68727-900RYLAZE (ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN) INJECTION [JAZZ PHARMACEUTICALS, INC.]6Current NDC, Legacy NDC, 2 package rows20241010_857e53aa-1098-4dad-b654-0276cdd43e03.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2561251asparaginase Erwinia chrysanthemi (recombinant)-rywn 10 MG in 0.5 ML InjectionPSN857e53aa-1098-4dad-b654-0276cdd43e037
2561256RYLAZE 10 MG in 0.5 ML InjectionPSN857e53aa-1098-4dad-b654-0276cdd43e037
25612560.5 ML asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML Injection [Rylaze]SBD857e53aa-1098-4dad-b654-0276cdd43e037
25612510.5 ML asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML InjectionSCD857e53aa-1098-4dad-b654-0276cdd43e037
25612560.5 ML Rylaze 20 MG/ML InjectionSY857e53aa-1098-4dad-b654-0276cdd43e037
2561251asparaginase Erwinia chrysanthemi (recombinant)-rywn 10 MG per 0.5 ML InjectionSY857e53aa-1098-4dad-b654-0276cdd43e037
2561256Rylaze 10 MG per 0.5 ML InjectionSY857e53aa-1098-4dad-b654-0276cdd43e037

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
68727-900-01687270900010.5 mL in 1 VIAL, SINGLE-DOSE0.5 mlHistorical
68727-900-03687270900033 VIAL, SINGLE-DOSE in 1 CARTON (68727-900-03) / .5 mL in 1 VIAL, SINGLE-DOSE (68727-900-01) 2021-06-300000-00-00NoNoCurrent